Literature DB >> 4288701

Studies on the heterologous immunogenicity of a methanol-insoluble fraction of attenuated tubercle bacilli (BCG). II. Protection against tumor isografts.

D W Weiss, R S Bonhag, P Leslie.   

Abstract

A methanol-insoluble residue (MER) of phenol-killed attenuated tubercle bacilli (BCG), which has been reported previously to be capable of evoking heightened resistance to infection with antigenically unrelated microorganisms, was found to affect as well the resistance of highly inbred mice against tumor isografts. In most instances, the MER evoked heightened resistance against the tumor implants, but heightened susceptibility was the effect induced against two of the tumors tested, and no effect was elicited against one neoplasm. It is suggested that the heightened susceptibility occasionally produced by pretreatment with MER may also be of immunological nature, i.e. immunological enhancement. Treatment with MER was more effective when administered some time before tumor challenge than when given simultaneously with, or after, tumor implantation. The protective effects manifested against some tumors were of a high order, a significant number of animals rejecting the neoplastic implants, and were displayed even when several months elapsed between treatment and challenge. Living BCG and intact phenol-killed bacilli also evoked heightened resistance against some of the tumors tested, and in one experiment living BCG proved effective whereas MER did not. On the whole, however, MER was the most active (and least toxic, as shown previously) of the several tubercle bacillus preparations tested. MER elicited heightened reactivity against first transplant generation tumors as well as against tumors maintained for considerable periods of time by repeated animal passage, and against spontaneously arising as well as against induced neoplasms. The experimental parameters necessary to demonstrate maximal effects varied somewhat from tumor to tumor. In general, however, single intraperitoneal injections of small quantities of MER, of the order of 0.25 to 1.0 mg, afforded the best protection.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4288701      PMCID: PMC2138325          DOI: 10.1084/jem.124.6.1039

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  ACQUISITION OF HEIGHTENED RESISTANCE AND SUSCEPTIBILITY TO SPONTANEOUS MOUSE MAMMARY CARCINOMAS IN THE ORIGINAL HOST.

Authors:  D W WEISS; L J FAULKIN; K B DEOME
Journal:  Cancer Res       Date:  1964-05       Impact factor: 12.701

2.  IMMUNITY TO SPONTANEOUS AND METHYLCHOLANTHRENE-INDUCED TUMORS IN INBRED MICE.

Authors:  R S RIGGINS; Y H PILCH
Journal:  Cancer Res       Date:  1964-12       Impact factor: 12.701

3.  IMMUNOLOGY OF SPONTANEOUS MAMMARY CARCINOMAS IN MICE. II. RESISTANCE TO A RAPIDLY AND A SLOWLY DEVELOPING TUMOR.

Authors:  M A ATTIA; K B DEOME; D W WEISS
Journal:  Cancer Res       Date:  1965-05       Impact factor: 12.701

4.  Histocompatibility changes in tumors.

Authors:  G KLEIN; E KLEIN
Journal:  J Cell Physiol Suppl       Date:  1958-12

5.  The immunological basis for non-infective Rous sarcomas.

Authors:  H RUBIN
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1962

6.  Vaccination against tuberculosis with nonliving vaccines. 3. Vaccination of guinea pigs with fractions of phenol-killed tubercle bacilli.

Authors:  D W WEISS; A Q WELLS
Journal:  Am Rev Respir Dis       Date:  1960-09

7.  Protective activity of fractions of tubercle bacilli against isologous tumours in mice.

Authors:  D W WEISS; R S BONHAG; K B DEOME
Journal:  Nature       Date:  1961-06-03       Impact factor: 49.962

8.  Factorial analysis of the reactivity of C57BL females against isologous male skin grafts.

Authors:  E KLEIN; O LINDER
Journal:  Plast Reconstr Surg       Date:  1961-04       Impact factor: 4.730

9.  Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.

Authors:  G KLEIN; H O SJOGREN; E KLEIN; K E HELLSTROM
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

10.  Immunology of spontaneous mammary carcinomas in mice. 3. Immunogenicity of C3H preneoplastic hyperplastic alveolar nodules in C3Hf hosts.

Authors:  D H Lavrin; P B Blair; D W Weiss
Journal:  Cancer Res       Date:  1966-02       Impact factor: 12.701

View more
  10 in total

1.  Modulation of the immune response by a methanol-insoluble fraction of attenuated tubercle bacilli (BCG). II. Relationship of antigen dose to heightened primary and secondary immune responses to sheep red blood cells.

Authors:  D J Yashphe
Journal:  Clin Exp Immunol       Date:  1972-12       Impact factor: 4.330

2.  Effect of splenectomy on the growth of adenovirus 12 tumors in hamsters.

Authors:  P Erb; L Baselgia; M Gasser; A Honegger; H Loeffler
Journal:  Experientia       Date:  1974-08-15

3.  Modulation of the immune response by a methanol-insoluble fraction of attenuated tubercle bacilli (BCG). I. Primary and secondary responses to sheep red blood cells and T2 phage.

Authors:  D J Yashphe; D W Weiss
Journal:  Clin Exp Immunol       Date:  1970-08       Impact factor: 4.330

4.  Studies on the mode of action of the heterologous immunogenicity of a methanol-insoluble fraction of attenuated tubercle bacilli (BCG).

Authors:  C B Steinkuller; L G Krigbaum; D W Weiss
Journal:  Immunology       Date:  1969-02       Impact factor: 7.397

5.  Enhancement of immunity against murine syngeneic tumors by a fraction extracted from non-pathogenic mycobacteria.

Authors:  A Lamensans; L Chedid; E Lederer; J P Rosselet; R H Gustafson; H J Spencer; B Ludwig; F M Berger
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

6.  Haemorrhagic tumour necrosis following endotoxin administration. I. Communication: morphological investigation on endotoxin-induced necrosis of the methylcholanthrene (Meth A) tumour in the mouse.

Authors:  N Freudenberg; K Joh; O Westphal; C Mittermayer; M A Freudenberg; C Galanos
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

Review 7.  Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy.

Authors:  Yuan-qiang Zheng; Youssef W Naguib; Yixuan Dong; Yan-chun Shi; Shorgan Bou; Zhengrong Cui
Journal:  Expert Rev Vaccines       Date:  2015       Impact factor: 5.217

8.  A preliminary report on the effects of methanol extraction residue of BCG (MER) on cancer patients.

Authors:  E Robinson; A Bartal; Y Cohen; R Haasz
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

9.  B.C.G. suppression of pulmonary metastases from primary rat hepatomata.

Authors:  R W Baldwin; M V Pimm
Journal:  Br J Cancer       Date:  1974-11       Impact factor: 7.640

10.  Specific enhancement of transplantation immunity with heat-killed Mycobacterium butyricum and immunizing extracts from adenovirus 12-induced tumour cells.

Authors:  R C Rees; C W Potter
Journal:  Br J Cancer       Date:  1972-04       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.